Astellas Pharma

From WikiMD's medical encyclopedia

Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, headquartered in Tokyo, Japan. The company was established on April 1, 2005, through the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. Astellas is involved in the research, development, manufacture, import, and export of pharmaceuticals.

History

The history of Astellas Pharma Inc. is marked by the merger of two leading Japanese pharmaceutical companies, Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. The merger was aimed at creating a more robust entity capable of competing on the global market.

Business Operations

Astellas Pharma Inc. operates in over 70 countries worldwide. The company's primary areas of focus include oncology, immunology, urology, and neuroscience. Astellas is also involved in the development of pharmaceuticals for infectious diseases and cardiovascular diseases.

Research and Development

Astellas Pharma Inc. has a strong commitment to research and development. The company's R&D efforts are focused on creating innovative drugs that can contribute to the health of patients around the world. Astellas has research facilities in Japan, North America, and Europe.

Products

Some of the key products of Astellas Pharma Inc. include Prograf, a drug used to prevent organ rejection in transplant patients, and Xtandi, a drug used to treat prostate cancer. The company also manufactures Vesicare, a drug used to treat overactive bladder.

Corporate Social Responsibility

Astellas Pharma Inc. is committed to fulfilling its corporate social responsibility through various initiatives. These include efforts to improve access to medicines, promote health education, and contribute to the sustainable development of society.

See Also

References


External Links

FlattenedRoundPills.jpg
This article is a stub related to pharmacology. You can help WikiMD by expanding it!


  • Astellas Pharma logo.svg

    Astellas Pharma Logo

  • Astellas Pharma Canada Office

  • 3D Structure of 2-arachidonoylglycerol

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Transform your life with W8MD's budget GLP-1 injections from $125.

W8mdlogo.png
W8MD weight loss doctors team

W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:

NYC weight loss doctor appointments

Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.

Linkedin_Shiny_Icon Facebook_Shiny_Icon YouTube_icon_(2011-2013) Google plus


Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/w/index.php?title=Astellas_Pharma&oldid=6309292"

Contributors: Prab R. Tumpati, MD